Related Experiment Video

Updated: Jun 2, 2026

Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
14:14

Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR

Published on: December 6, 2014

Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency

Mirjam van der Burg1, Andy R Gennery

  • 1Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 50, Rotterdam 3015 GE, The Netherlands. m.vanderburg@erasmusmc.nl

European Journal of Pediatrics
|April 12, 2011
PubMed

Insights

Severe combined immunodeficiency (SCID) is a critical pediatric emergency due to absent T lymphocytes. Early diagnosis and treatment are vital for survival, despite varied clinical and immunological presentations.

Area of Science:

  • Immunology
  • Pediatrics
  • Genetics

Background:

  • Severe combined immunodeficiency (SCID) is a life-threatening pediatric emergency.
  • Characterized by a lack of functional T lymphocytes, SCID presents with diverse clinical and immunological variations.
  • Delayed diagnosis significantly increases mortality risk.

Purpose of the Study:

  • To provide an educational review of SCID.
  • To elucidate the immunopathological basis, clinical manifestations, and diagnostic challenges of SCID.
  • To outline current and potential therapeutic strategies for SCID.

Main Methods:

  • Literature review of SCID.
  • Analysis of immunopathological mechanisms.
  • Synthesis of clinical presentation data.
  • Review of diagnostic approaches.
  • Compilation of therapeutic options.

Main Results:

  • SCID encompasses classical, atypical, and Omenn syndrome forms.
  • Significant immunological heterogeneity complicates diagnosis.
  • Understanding immunopathology is key to diagnosis and treatment.

Conclusions:

  • SCID requires prompt recognition and management.
  • Multifaceted diagnostic approaches are necessary.
  • Therapeutic interventions are crucial for improving outcomes in SCID patients.

More Related Videos

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview